無菌活性医薬品成分の世界市場インサイト2019-2029

• 英文タイトル:Sterile Active Pharmaceutical Ingredients Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029

Sterile Active Pharmaceutical Ingredients Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029「無菌活性医薬品成分の世界市場インサイト2019-2029」(市場規模、市場予測)調査レポートです。• レポートコード:PMR20MY020
• 出版社/出版日:Persistence Market Research / 2020年2月7日
• レポート形態:英文、PDF、170ページ
• 納品方法:Eメール
• 産業分類:健康管理
• 販売価格(消費税別)
  Individual User(1名用)¥486,000 (USD4,500)▷ お問い合わせ
  Multi User(5名用)¥702,000 (USD6,500)▷ お問い合わせ
  Corporate User(企業用)¥918,000 (USD8,500)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界の無菌活性医薬品成分市場について調査・分析し、エグゼクティブサマリー、市場概要、市場動向、市場背景、北米、中南米、ヨーロッパ、南アジア、東アジア、オセアニア市場分析及び予測などを含め、以下の構成でお届け致します。
・世界の無菌活性医薬品成分市場:エグゼクティブサマリー
・世界の無菌活性医薬品成分市場:概要
・世界の無菌活性医薬品成分市場:動向
・世界の無菌活性医薬品成分市場:背景
・北米の無菌活性医薬品成分市場:分析及び予測
・中南米の無菌活性医薬品成分市場:分析及び予測
・ヨーロッパの無菌活性医薬品成分市場:分析及び予測
・南アジアの無菌活性医薬品成分市場:分析及び予測
・東アジアの無菌活性医薬品成分市場:分析及び予測
・オセアニアの無菌活性医薬品成分市場:分析及び予測

Sterile Active Pharmaceutical Ingredients Market – Scope of the Report

Fact.MR recently published a market study on the global market for sterile active pharmaceutical ingredients. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities restraints, and detailed information about the sterile active pharmaceutical ingredients market structure. The market study presents exclusive information about how the sterile active pharmaceutical ingredients market will grow during the forecast period (2019-2029).

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in Fact.MR’s study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the sterile active pharmaceutical ingredients market during the forecast period.

The study is relevant for stakeholders in the sterile active pharmaceutical ingredients market, including sterile active pharmaceutical ingredients manufacturers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the sterile active pharmaceutical ingredients market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in Fact.MR’s study.

The study also includes statistics as well as facts related to macro as well as microeconomic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the sterile active pharmaceutical ingredients market. Furthermore, small businesses and new entrants in the sterile active pharmaceutical ingredients market too can make use of the information presented in this study, based on which, they can make appropriate business decisions to gain momentum in the market.

Key Questions Answered in Fact.MR’s Sterile Active Pharmaceutical Ingredients Market Report

Which regions will continue to remain the most profitable regional markets for sterile active pharmaceutical ingredients market players?
Which factors will induce a change in the demand for sterile active pharmaceutical ingredients manufacturers during the assessment period?
How will changing trends impact the sterile active pharmaceutical ingredients market?
How can market players capture the low-hanging opportunities in the sterile active pharmaceutical ingredients market in developed regions?
Which companies are leading the sterile active pharmaceutical ingredients market?
What are the winning strategies of stakeholders in the sterile active pharmaceutical ingredients market to upscale their position in this landscape?
Sterile Active Pharmaceutical Ingredients Market: Research Methodology

In Fact.MR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the sterile active pharmaceutical ingredients market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of conclusions.

Secondary resources referred to analysts during the production of the sterile active pharmaceutical ingredients market study include statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the sterile active pharmaceutical ingredients market, and makes Fact.MR’s projection on the growth prospects of the sterile active pharmaceutical ingredients market more accurate and reliable.

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Technology Trends

4. Market Background

4.1. Macro-Economic Factors

4.2. Forecast Factors – Relevance & Impact

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunity Analysis

4.4. Parent Market Analysis

5. Global Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type

5.1. Introduction / Key Findings

5.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014-2018

5.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019-2029

5.3.1. Monoclonal Antibody

5.3.2. Immunoglobulin

5.3.3. Cytokines

5.3.4. Insulin

5.3.5. Peptide Hormones

5.3.6. Blood Factors

5.3.7. Peptide Antibiotics

5.3.8. Vaccines

5.3.9. Small Molecule Antibiotics

5.3.10. Highly Potent Active Pharmaceutical Ingredients (HPAPI)

5.3.11. Others

5.4. Market Attractiveness Analysis By Product Type

6. Global Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029, by Form

6.1. Introduction / Key Findings

6.2. Historical Market Size (US$ Mn) Analysis By Form, 2014-2018

6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Form, 2019-2029

6.3.1. Aqueous

6.3.2. Non-aqueous liquid

6.3.3. Dry powder

6.4. Market Attractiveness Analysis By Form

7. Global Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029, by Region

7.1. Introduction

7.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018

7.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019-2029

7.3.1. North America

7.3.2. Latin America

7.3.3. Europe

7.3.4. East Asia

7.3.5. South Asia

7.3.6. Oceania

7.3.7. Middle East and Africa (MEA)

7.4. Market Attractiveness Analysis By Region

8. North America Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029

8.1. Introduction

8.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

8.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

8.3.1. By Country

8.3.1.1. U.S.

8.3.1.2. Canada

8.3.2. By Product Type

8.3.3. By Form

8.4. Market Attractiveness Analysis

8.4.1. By Country

8.4.2. By Product Type

8.4.3. By Form

9. Latin America Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

9.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

9.3.1. By Country

9.3.1.1. Brazil

9.3.1.2. Mexico

9.3.1.3. Rest of Latin America

9.3.2. By Product Type

9.3.3. By Form

9.4. Market Attractiveness Analysis

9.4.1. By Country

9.4.2. By Product Type

9.4.3. By Form

10. Europe Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

10.3.1. By Country

10.3.1.1. Germany

10.3.1.2. Italy

10.3.1.3. France

10.3.1.4. U.K.

10.3.1.5. Spain

10.3.1.6. Russia

10.3.1.7. Rest of Europe

10.3.2. By Product Type

10.3.3. By Form

10.4. Market Attractiveness Analysis

10.4.1. By Country

10.4.2. By Product Type

10.4.3. By Form

11. South Asia Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

11.3.1. By Country

11.3.1.1. India

11.3.1.2. Thailand

11.3.1.3. Indonesia

11.3.1.4. Malaysia

11.3.1.5. Rest of South Asia

11.3.2. By Product Type

11.3.3. By Form

11.4. Market Attractiveness Analysis

11.4.1. By Country

11.4.2. By Product Type

11.4.3. By Form

12. East Asia Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

12.3.1. By Country

12.3.1.1. China

12.3.1.2. Japan

12.3.1.3. South Korea

12.3.2. By Product Type

12.3.3. By Form

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Product Type

12.4.3. By Form

13. Oceania Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

13.3.1. By Country

13.3.1.1. Australia

13.3.1.2. New Zealand

13.3.2. By Product Type

13.3.3. By Form

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Product Type

13.4.3. By Form

14. Middle East and Africa Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

14.3.1. By Country

14.3.1.1. GCC Countries

14.3.1.2. Turkey

14.3.1.3. Northern Africa

14.3.1.4. South Africa

14.3.1.5. Rest of Middle East and Africa

14.3.2. By Product Type

14.3.3. By Form

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Product Type

14.4.3. By Form

15. Emerging Countries Sterile Active Pharmaceutical Ingredients Market Analysis 2014-2018 and Forecast 2019-2029

15.1. Introduction

15.1.1. Market Value Proportion Analysis, By Key Countries

15.1.2. Global Vs. Country Growth Comparison

15.2. China Sterile Active Pharmaceutical Ingredients Market Analysis

15.2.1. Introduction

15.2.2. Market Value Proportion Analysis by Market Taxonomy

15.2.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

15.2.3.1. By Product Type

15.2.3.2. By Form

15.3. Mexico Sterile Active Pharmaceutical Ingredients Market Analysis

15.3.1. Introduction

15.3.2. Market Value Proportion Analysis by Market Taxonomy

15.3.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

15.3.3.1. By Product Type

15.3.3.2. By Form

15.4. India Sterile Active Pharmaceutical Ingredients Market Analysis

15.4.1. Introduction

15.4.2. Market Value Proportion Analysis by Market Taxonomy

15.4.3. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy

15.4.3.1. By Product Type

15.4.3.2. By Form

16. Market Structure Analysis

17. Competition Analysis

17.1. Competition Dashboard

17.2. Competition Deep Dive

17.2.1. Aurobindo Pharma Limited

17.2.1.1. Overview

17.2.1.2. Sterile API Portfolio

17.2.1.3. Key Financials

17.2.1.4. Key Developments

17.2.1.5. Analyst Commentary

17.2.2. Teva Pharmaceutical Industries Ltd.

17.2.2.1. Overview

17.2.2.2. Sterile API Portfolio

17.2.2.3. Key Financials

17.2.2.4. Key Developments

17.2.2.5. Analyst Commentary

17.2.3. Corden Pharma GmbH

17.2.3.1. Overview

17.2.3.2. Sterile API Portfolio

17.2.3.3. Key Financials

17.2.3.4. Key Developments

17.2.3.5. Analyst Commentary

17.2.4. Dalton Pharma Services

17.2.4.1. Overview

17.2.4.2. Sterile API Portfolio

17.2.4.3. Key Financials

17.2.4.4. Key Developments

17.2.4.5. Analyst Commentary

17.2.5. Pfizer Inc.

17.2.5.1. Overview

17.2.5.2. Sterile API Portfolio

17.2.5.3. Key Financials

17.2.5.4. Key Developments

17.2.5.5. Analyst Commentary

17.2.6. Sun Pharmaceutical Industries Ltd.

17.2.6.1. Overview

17.2.6.2. Sterile API Portfolio

17.2.6.3. Key Financials

17.2.6.4. Key Developments

17.2.6.5. Analyst Commentary

17.2.7. Lonza Group

17.2.7.1. Overview

17.2.7.2. Sterile API Portfolio

17.2.7.3. Key Financials

17.2.7.4. Key Developments

17.2.7.5. Analyst Commentary

17.2.8. Albany Molecular Research Inc.

17.2.8.1. Overview

17.2.8.2. Sterile API Portfolio

17.2.8.3. Key Financials

17.2.8.4. Key Developments

17.2.8.5. Analyst Commentary

17.2.9. Sanofi S.A

17.2.9.1. Overview

17.2.9.2. Sterile API Portfolio

17.2.9.3. Key Financials

17.2.9.4. Key Developments

17.2.9.5. Analyst Commentary

17.2.10. Dr. Reddy’s Laboratories Ltd

17.2.10.1. Overview

17.2.10.2. Sterile API Portfolio

17.2.10.3. Key Financials

17.2.10.4. Key Developments

17.2.10.5. Analyst Commentary

18. Assumptions and Acronyms Used

19. Research Methodology

List of Tables

Table 01: Global Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029 By Product Type

Table 02: Global Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029 By Form

Table 03: Global Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029 By Region

Table 04: North America Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Country

Table 05: North America Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type

Table 06: North America Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form

Table 07: Latin America Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Country

Table 08: Latin America Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type

Table 09: Latin America Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form

Table 10: Europe Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Country

Table 11: Europe Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type

Table 12: Europe Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form

Table 13: South Asia Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Country

Table 14: South Asia Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type

Table 15: South Asia Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form

Table 16: East Asia Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Country

Table 17: East Asia Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type

Table 18: East Asia Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form

Table 19: Oceania Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Country

Table 20: Oceania Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type

Table 21: Oceania Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form

Table 22: Middle East & Africa Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Country

Table 23: Middle East & Africa Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type

Table 24: Middle East & Africa Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form

Table 25: China Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type

Table 26: China Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form

Table 27: Mexico Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type

Table 28: Mexico Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form

Table 29: India Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Product Type

Table 30: India Sterile Active Pharmaceutical Ingredients Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019-2029 By Form


• 英文レポート名:Sterile Active Pharmaceutical Ingredients Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2019 to 2029
• 日本語訳:無菌活性医薬品成分の世界市場インサイト2019-2029
• レポートコード:PMR20MY020お問い合わせ(見積依頼・ご注文・質問)